Non-invasive diagnosis of vasospastic angina.
Ergonovine
Microvascular spasm
Positron emission tomography
Prinzmetal
Single-photon emission tomography
Variant angina
Vasospasm
Journal
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
ISSN: 1532-6551
Titre abrégé: J Nucl Cardiol
Pays: United States
ID NLM: 9423534
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
received:
16
02
2022
accepted:
18
02
2022
pubmed:
25
3
2022
medline:
8
3
2023
entrez:
24
3
2022
Statut:
ppublish
Résumé
Vasospastic angina (VSA), or variant angina, is an under-recognized cause of chest pain and myocardial infarction, especially in Western countries. VSA leads to a declined quality of life and is associated with increased morbidity and mortality. Currently, the diagnosis of VSA relies on invasive testing that requires the direct intracoronary administration of ergonovine or acetylcholine. However, invasive vasoreactivity testing is underutilized. Several non-invasive imaging alternatives have been proposed to screen for VSA. This review aims to discuss the strengths and limitations of available non-invasive imaging tests for vasospastic angina.
Identifiants
pubmed: 35322379
doi: 10.1007/s12350-022-02948-z
pii: 10.1007/s12350-022-02948-z
doi:
Substances chimiques
Ergonovine
WH41D8433D
Acetylcholine
N9YNS0M02X
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
167-177Informations de copyright
© 2022. The Author(s) under exclusive licence to American Society of Nuclear Cardiology.
Références
Prinzmetal M, Kennamer R, Merliss R, Wada T, Bor N. Angina pectoris I. A variant form of angina pectoris. Preliminary report. Am J Med 1959;27:375‐88.
pubmed: 14434946
Kaski JC, Collins P, Nihoyannopoulos P, Maseri A, Poole-Wilson PA, Rosano GMC. Cardiac syndrome X: Clinical characteristics and left ventricular function: long-term follow-up study. J Am Coll Cardiol 1995;25:807‐14.
pubmed: 7884081
Guidelines JCS. Guidelines for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina) (jcs 2008). Circ J 2010;74:1745‐62.
Beltrame JF, Crea F, Kaski JC, Ogawa H, Ong P, Sechtem U. International standardization of diagnostic criteria for vasospastic angina. Eur Heart J 2017;38:2565‐8.
pubmed: 26245334
Yasue H, Nakagawa H, Itoh T, Harada E. Coronary artery spasm—Clinical features, diagnosis, pathogenesis, and treatment. 2008:2-17.
Pristipino C, Beltrame JF, Finocchiaro ML, Hattori R, Fujita M, Mongiardo R, et al. Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction. Circulation 2000;101:1102‐8.
pubmed: 10715255
Pikkarainen E, Blomster J, Sipilä J, Rautava P, Kytö V. Occurrence and mortality of vasospastic angina pectoris hospitalised patients in based registry Finland: a population—cohort study. 2019:1-7.
Ong P, Athanasiadis A, Borgulya G, Mahrholdt H, Kaski JC, Sechtem U. High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries: The ACOVA study (abnormal coronary vasomotion in patients with stable angina and unobstructed coronary arteries. J Am Coll Cardiol 2012;59:655‐62.
pubmed: 22322081
Choi BG, Rha SW, Yoon SG, Choi CU, Lee MW, Kim SW. Association of major adverse cardiac events up to 5 years in patients with chest pain without significant coronary artery disease in the Korean population. J Am Heart Assoc 2019;8:e010541.
Ong P, Athanasiadis A, Hill S, Vogelsberg H, Voehringer M, Sechtem U. Coronary artery spasm as a frequent cause of acute coronary syndrome. The CASPAR (Coronary Artery Spasm in Patients With Acute Coronary Syndrome) Study. J Am Coll Cardiol 2008;52:523-7.
Kang WY, Jeong MH, Ahn YK, Kim JH, Chae SC, Kim YJ, et al. Are patients with angiographically near-normal coronary arteries who present as acute myocardial infarction actually safe? Int J Cardiol 2011;146:207‐12.
pubmed: 19664828
Kim JB, Choi BG, Rha SW, Seo HS, Choi SY, Byun JK, et al. Clinical characteristics and outcomes of patients with coronary artery spasm who initially presented with acute myocardial infarction. Coron Artery Dis 2018;29:60‐7.
pubmed: 29176378
Laporte F, Moulin F, Brembilla-Perrot B. Sudden death caused by atypical variant angina. Arch Cardiovasc Dis 2011;104:480‐1.
pubmed: 21944150
Nobuyoshi M, Tanaka M, Nosaka H, Kimura T, Yokoi H, Hamasaki N, et al. Progression of coronary atherosclerosis: Is coronary spasm related to progression? J Am Coll Cardiol 1991;18:904‐10.
pubmed: 1894863
Ozaki Y, Keane D, Serruys PW. Progression and regression of coronary stenosis in the long-term follow-up of vasospastic angina. Circulation 1995;92:2446‐56.
pubmed: 7586344
Kim DW, Her SH, Ahn Y, Shin DI, Han SH, Kim DS, et al. Clinical outcome according to spasm type of single coronary artery provoked by intracoronary ergonovine tests in patients without significant organic stenosis. Int J Cardiol 2018;252:6‐12.
pubmed: 29249438
Saito Y, Kitahara H, Shoji T, Tokimasa S, Nakayama T, Sugimoto K, et al. Feasibility and safety of outpatient cardiac catheterization with intracoronary acetylcholine provocation test. Heart Vessels 2018;33:846‐52.
pubmed: 29435640
Sato K, Kaikita K, Nakayama N, Horio E, Yoshimura H, Ono T et al. Coronary vasomotor response to intracoronary acetylcholine injection, clinical features, and long-term prognosis in 873 consecutive patients with coronary spasm: analysis of a single-center study over 20 years. J Am Heart Assoc 2013;2:e000227.
Ford TJ, Ong P, Sechtem U, Beltrame J, Camici PG, Crea F, et al. Assessment of vascular dysfunction in patients without obstructive coronary artery disease: Why, how, and when. JACC Cardiovasc Interv 2020;13:1847‐64.
pubmed: 32819476
pmcid: 7447977
Kaski JC, Crea F, Gersh BJ, Camici PG. Reappraisal of ischemic heart disease. Circulation 2018;138:1463‐80.
pubmed: 30354347
Suda A, Takahashi J, Hao K, Kikuchi Y, Shindo T, Ikeda S, et al. Coronary functional abnormalities in patients with angina and nonobstructive coronary artery disease. J Am Coll Cardiol 2019;74:2350‐60.
pubmed: 31699275
Sun H, Mohri M, Shimokawa H, Usui M, Urakami L, Takeshita A. Coronary microvascular spasm causes myocardial ischemia in patients with vasospastic angina. J Am Coll Cardiol 2002;39:847‐51.
pubmed: 11869851
Heupler FA Jr. Provocative testing for coronary arterial spasm: risk, method and rationale. Am J Cardiol 1980;46:335‐7.
pubmed: 7405847
Fournier JA, Cortacero JA, Turá A, Hernández-Aparicio C, Granado C, Vallejo J. Effects of intracoronary injection of ergonovine on angiographic normal coronary arteries: study of 108 consecutive patients. Clin Cardiol 1989;12:561‐8.
pubmed: 2805461
Yasue H, Horio Y, Nakamura N, Fujii H, Imoto N, Sonoda R, et al. Induction of coronary artery spasm by acetylcholine in patients with variant angina: possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. Circulation 1986;74:955‐63.
pubmed: 3769179
Aronson JK. 76 - Plant Poisons and Traditional Medicines. In: Farrar J, Hotez PJ, Junghanss T, Kang G, Lalloo D, White NJ editors. Manson's tropical infectious diseases (Twenty-third Edition). London; 2014. p. 1128-50.e6.
Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 2020;41:407‐77.
pubmed: 31504439
Sueda S, Kohno H, Fukuda H, Ochi N, Kawada H, Hayashi Y, et al. Induction of coronary artery spasm by two pharmacological agents: Comparison between intracoronary injection of acetylcholine and ergonovine. Coron Artery Dis 2003;14:451‐7.
pubmed: 12966266
Kanazawa K, Suematsu M, Ishida T, Hirata KI, Kawasihma S, Aktta H, et al. Disparity between serotonin- and acetylcholine-provoked coronary artery spasm. Clin Cardiol 1997;20:146‐52.
pubmed: 9034644
Kunadian V, Chieffo A, Camici PG, Berry C, Escaned J, Maas A, et al. An EAPCI expert consensus document on ischaemia with non-obstructive coronary arteries in collaboration with European society of cardiology working group on coronary pathophysiology & microcirculation endorsed by coronary vasomotor disorders international study group. Eur Heart J 2020;41:3504‐20.
pubmed: 32626906
pmcid: 7577516
Zaya M, Mehta PK, Merz CN. Provocative testing for coronary reactivity and spasm. J Am Coll Cardiol 2014;63:103‐9.
pubmed: 24201078
Sueda S, Kohno H, Ochi T, Uraoka T, Tsunemitsu K. Overview of the pharmacological spasm provocation test: Comparisons between acetylcholine and ergonovine. J Cardiol 2017;69:57‐65.
pubmed: 27856130
Gulati M, Levy PD, Mukherjee D, Amsterdam E, Bhatt DL, Birtcher KK, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. J Cardiovasc Comput Tomogr 2022;16:54‐122.
pubmed: 34955448
Waters DD, Szlachcic J, Bonan R, Miller DD, Dauwe F, Theroux P. Comparative sensitivity of exercise, cold pressor and ergonovine testing in provoking attacks of variant angina in patients with active disease. Circulation 1983;67:310‐5.
pubmed: 6848218
Buxton A, Goldberg S, Hirshfeld JW, Wilson J, Mann T, Williams DO, et al. Refractory ergonovine-induced coronary vasospasm: Importance of intracoronary nitroglycerin. Am J Cardiol 1980;46:329‐34.
pubmed: 6773407
Sueda S, Kohno H. Overview of complications during pharmacological spasm provocation tests. J Cardiol 2016;68:1‐6.
pubmed: 27234219
Om SY, Yoo S-Y, Cho G-Y, Kim M, Woo Y, Lee S, et al. Diagnostic and prognostic value of ergonovine echocardiography for noninvasive diagnosis of coronary vasospasm. JACC Cardiovasc Imaging 2020;13:1875‐87.
pubmed: 32417336
Whittle JL, Feldman RL, Pepine CJ, Curry RC, Conti CR, Gainesville MD. Variability of electrocardiographic responses repeated ergonovine provocation in variant angina patients with coronary artery spasm to1982.
Curry RC Jr, Pepine CJ, Sabom MB, Feldman RL, Christie LG, Conti CR. Effects of ergonovine in patients with and without coronary artery disease. Circulation 1977;56:803‐9.
pubmed: 912842
Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, et al. ESC guidelines on the management of stable coronary artery disease. Eur Heart J 2013;34:2949‐3003.
pubmed: 23996286
Om SY, Yoo SY, Cho GY, Kim M, Woo Y, Lee S et al. Diagnostic and prognostic value of ergonovine echocardiography for noninvasive diagnosis of coronary vasospasm. JACC: Cardiovasc Imaging 2020;13:1875–1887.
Song JK, Park SW, Kang DH, Hong MK, Kim JJ, Lee CW, et al. Safety and clinical impact of ergonovine stress echocardiography for diagnosis of coronary vasospasm. J Am Coll Cardiol 2000;35:1850‐6.
pubmed: 10841234
Song JK, Park SW, Kim JJ, Doo YC, Kim WH, Park SJ, et al. Values of intravenous ergonovine test with two-dimensional echocardiography for diagnosis of coronary artery spasm. J Am Soc Echocardiogr 1994;7:607‐15.
pubmed: 7840988
Song J-K, Lee SJ-K, Kang D-H, Cheong SS, Hong MK, Kim J-J et al. Ergonovine echocardiography as a screening test for diagnosis of vasospastic angina before coronary angiography. J Am Coll Cardiol 1996;27:1156-61.
Djordjevic-Dikic A, Varga A, Rodriguez O, Morelos M, Sicari R, Del Negro B, et al. Safety of ergotamine-ergic pharmacologic stress echocardiography for vasospasm testing in the echo lab: 14 year experience on 478 tests in 464 patients. Cardiologia 1999;44:901‐6.
pubmed: 10630049
Song JK, Lee SJ, Kang DH, Cheong SS, Hong MK, Kim JJ, et al. Ergonovine echocardiography as a screening test for diagnosis of vasospastic angina before coronary angiography. J Am Coll Cardiol 1996;27:1156‐61.
pubmed: 8609335
Germino M, Ropchan J, Mulnix T, Fontaine K, Nabulsi N, Ackah E, et al. Quantification of myocardial blood flow with (82)Rb: Validation with (15)O-water using time-of-flight and point-spread-function modeling. EJNMMI Res 2016;6:68.
pubmed: 27650280
pmcid: 5030203
Bol A, Melin JA, Vanoverschelde JL, Baudhuin T, Vogelaers D, De Pauw M, et al. Direct comparison of [13N]ammonia and [15O]water estimates of perfusion with quantification of regional myocardial blood flow by microspheres. Circulation 1993;87:512‐25.
pubmed: 8425298
Nitzsche EU, Choi Y, Czernin J, Hoh CK, Huang SC, Schelbert HR. Noninvasive quantification of myocardial blood flow in humans. A direct comparison of the [13N]ammonia and the [15O]water techniques. Circulation 1996;93:2000-6.
Lortie M, Beanlands RS, Yoshinaga K, Klein R, Dasilva JN, DeKemp RA. Quantification of myocardial blood flow with 82Rb dynamic PET imaging. Eur J Nucl Med Mol Imaging 2007;34:1765‐74.
pubmed: 17619189
Pelletier-Galarneau M, Dilsizian V. Microvascular angina diagnosed by absolute PET myocardial blood flow quantification. Curr Cardiol Rep 2020;22:9.
pubmed: 31993834
Pelletier-Galarneau M, Martineau P, El Fakhri G. Quantification of PET myocardial blood flow. Curr Cardiol Rep 2019;21:11.
pubmed: 30815744
Yasue H, Omote S, Takizawa A, Nagao M, Miwa K, Tanaka S. Circadian variation of exercise capacity in patients with Prinzmetal’s variant angina: role of exercise-induced coronary arterial spasm. Circulation 1979;59:938‐48.
pubmed: 428106
Yasue H, Touyama M, Kato H, Tanaka S, Akiyama F. Prinzmetal’s variant form of angina as a manifestation of alpha-adrenergic receptor-mediated coronary artery spasm: documentation by coronary arteriography. Am Heart J 1976;91:148‐55.
pubmed: 813507
Fuller CM, Raizner AE, Chahine RA, Nahormek P, Ishimori T, Verani M, et al. Exercise-induced coronary arterial spasm: angiographic demonstration, documentation of ischemia by myocardial scintigraphy and results of pharmacologic intervention. Am J Cardiol 1980;46:500‐6.
pubmed: 7415995
Waters DD, Chaitman BR, Dupras G, Théroux P, Mizgala HF. Coronary artery spasm during exercise in patients with variant angina. Circulation 1979;59:580‐5.
pubmed: 761339
Kugiyama K, Yasue H, Okumura K, Minoda K, Takaoka K, Matsuyama K, et al. Simultaneous multivessel coronary artery spasm demonstrated by quantitative analysis of thallium-201 single photon emission computed tomography. Am J Cardiol 1987;60:1009‐14.
pubmed: 3499809
Aoki M, Koyanagi S, Sakai K, Irie T, Takeshita A, Nakamura M, et al. Exercise-induced silent myocardial ischemia in patients with vasospastic angina. Am Heart J 1990;119:551‐6.
pubmed: 2309598
Matsumura K, Nakase E, Haiyama T, Hasegawa A. Saito T [Evaluation of coronary hemodynamics and exercise 201Tl-myocardial scintigraphy in patients with vasospastic angina]. Kaku Igaku 1992;29:615‐23.
pubmed: 1434076
Sakata K, Yoshida H, Sugino H, Iimuro M, Matsunaga Y, Ono N, et al. Assessment of quantitative exercise thallium-201 emission computed tomography in patients with vasospastic angina–value of washout rate analysis. Jpn Circ J 1994;58:379‐88.
pubmed: 8065009
Nakajima K, Shimizu K, Taki J, Uetani Y, Konishi S, Tonami N, et al. Utility of iodine-123-BMIPP in the diagnosis and follow-up of vasospastic angina. J Nucl Med 1995;36:1934‐40.
pubmed: 7472578
Hata H, Okamatsu S, Tanaka J. Myocardial blood flow during exercise in patients with single-vessel or multivessel coronary spasms. Curr Ther Res 1995;56:1076‐86.
Fujita H, Yamabe H, Yokoyama M. Dipyridamole-induced reversible thallium-201 defect in patients with vasospastic angina and nearly normal coronary arteries. Clin Cardiol 2000;23:24‐30.
pubmed: 10680026
Cheng CW, Yang NI, Lin KJ, Hung MJ, Cherng WJ. Role of coronary spasm for a positive noninvasive stress test result in angina pectoris patients without hemodynamically significant coronary artery disease. Am J Med Sci 2008;335:354‐62.
pubmed: 18480651
Teragawa H, Ueda K, Okuhara K, Kuwashima R, Fukuda Y, Kiguchi M, et al. Coronary vasospasm produces reversible perfusion defects observed during adenosine triphosphate stress myocardial single-photon emission computed tomography. Clin Cardiol 2008;31:310‐6.
pubmed: 18636477
pmcid: 6653485
Xiang DC, Yin JL, He JX, Gong ZH. Resting chest pain, negative treadmill exercise electrocardiogram, and reverse redistribution in dipyridamole myocardial perfusion scintigraphy might be the features of coronary artery spasm. Clin Cardiol 2007;30:522‐6.
pubmed: 17929283
pmcid: 6653501
Saito S, Dodi S, Naito H. Hyperventilation induced coronary artery spasm during anesthesia for neurosurgery. J Anesth 1991;5:309‐12.
pubmed: 15278637
Fujii H, Yasue H, Okumura K, Matsuyama K, Morikami Y, Miyagi H, et al. Hyperventilation-induced simultaneous multivessel coronary spasm in patients with variant angina: an echocardiographic and arteriographic study. J Am Coll Cardiol 1988;12:1184‐92.
pubmed: 3170961
Imamura T, Nagatomo Y, Nakagawa S, Koiwaya Y, Hoshi H, Watanabe K, et al. Hyperventilation thallium-201 myocardial imaging for the diagnosis of vasospastic angina. Clin Nucl Med 1987;12:729‐34.
pubmed: 3665317
Minoda K, Yasue H, Kugiyama K, Okumura K, Motomura K, Shimomura O, et al. Comparison of the distribution of myocardial blood flow between exercise-induced and hyperventilation-induced attacks of coronary spasm: a study with thallium-201 myocardial scintigraphy. Am Heart J 1994;127:1474‐80.
pubmed: 8197971
Katamura M, Matsumuro A, Tamagaki S, Matoba S, Tsuji HKitamura M, et al. Clinical significance of diffuse vasoconstriction of coronary arteries—A study using hyperventilation thallium-201 myocardial imaging. Kaku Igaku 1995;32:479‐86.
pubmed: 7596068
Falstie-Jensen N, Engby B, Rasmussen K, Bagger JP, Thuesen L, Tågehøj-Jensen F. Vasospastic angina assessed by hyperventilation-thallium-201 myocardial scintigraphy. Acta Med Scand 1987;222:133‐6.
pubmed: 3673666
Masuoka T, Ajisaka R, Watanabe S, Yamanouchi T, Iida K, Sato M, et al. Usefulness of hyperventilation thallium-201 single photon emission computed tomography for the diagnosis of vasospastic angina. Jpn Heart J 1995;36:405‐20.
pubmed: 7474357
Group JJW. Guidelines for diagnosis and treatment of patients with vasospastic angina (Coronary Spastic Angina) (JCS 2013). Circ J 2014;78:2779‐801.
DiCarlo LA Jr, Botvinick EH, Canhasi BS, Schwartz AS, Chatterjee K. Value of noninvasive assessment of patients with atypical chest pain and suspected coronary spasm using ergonovine infusion and thallium-201 scintigraphy. Am J Cardiol 1984;54:744‐8.
pubmed: 6486023
Freedman SB, Dunn RF, Bernstein L, Richmond DR, O’Neill G, Kelly DT. Coronary artery spasm: use of ergonovine in diagnosis. Aust N Z J Med 1980;10:6‐11.
pubmed: 6929678
Narita M, Kurihara T, Usami M. Noninvasive detection of coronary artery disease by myocardial imaging with thallium-201 - the significance of pharmacologic interventions. Jpn Circ J 1981;45:127‐40.
pubmed: 6779029
Parodi O, Simonetti I. Vasospastic angina. Clin Invest Med 1980;3:119‐27.
pubmed: 7008995
Pfisterer M, Müller-Brand J, Cueni T, Lütold B, Burkart F. “Variant” angina: evidence for small vessel coronary artery spasm? Eur J Nucl Med 1980;5:529‐33.
pubmed: 7460977
Schwartz AB, Donmichael TA, Botvinick EH, Ishimori T, Parmley WW, Chatterjee K. Variability in coronary hemodynamics in response to ergonovine in patients with normal coronary arteries and atypical chest pain. J Am Coll Cardiol 1983;1:797‐803.
pubmed: 6826971
Shanes JG, Krone RJ, Fisher K, Shah B, Eisenkramer G, Humphrey JR. Noninvasive ergonovine maleate provocative testing for coronary artery spasm: The need for routine thallium-201 imaging. Cathet Cardiovasc Diagn 1983;9:271‐82.
pubmed: 6883499
Shanes JG, Pavel D, Blend M. Comparison of electrocardiography and thallium-201 myocardial scintigraphy for the detection of ergonovine-induced coronary artery spasm: Angiographic correlation. Am Heart J 1987;113:663‐71.
pubmed: 3825855
Shimada T, Ishibashi Y, Murakami Y, Sano K, Tsukihashi H, Okada S, et al. Myocardial ischemia due to vasospasm of small coronary arteries detected by methylergometrine maleate stress myocardial scintigraphy. Clin Cardiol 1999;22:795‐802.
pubmed: 10626082
Jolicœur EM, Pelletier-Galarneau M. Rubidium-82 positron emission tomography with intravenous ergonovine to diagnose vasospastic angina. Can J Cardiol 2021.
Yoneyama K, Akashi YJ, Kida K, Ashikaga K, Musha H, Suzuki K, et al. Metabolic planar imaging using 123I-β-methyl-iodophenyl pentadecanoic acid identifies myocardial ischemic memory after intracoronary acetylcholine provocation tests in patients with vasospastic angina. Int Heart J 2014;55:113‐8.
pubmed: 24632951
Watanabe K, Ohta Y, Toba K, Ogawa Y, Aizawa Y, Tanabe N, et al. Abnormal fatty acid metabolism in patients with coronary vasospasm. Ann Nucl Med 1999;13:33‐41.
pubmed: 10202946
Nakano A, Lee JD, Shimizu H, Tsubokawa A, Uzui H, Tsuchida T, et al. Clinical significance of reverse redistribution on resting thallium-201 imaging in patients with vasospastic angina. Ann Nucl Med 2001;15:65‐8.
pubmed: 11355786
Sueda S, Oshita A, Izoe Y, Kohno H, Fukuda H, Ochi T, et al. A long-acting calcium antagonist over one year did not improve BMIPP myocardial scintigraphic imagings in patients with pure coronary spastic angina. Ann Nucl Med 2007;21:85‐92.
pubmed: 17424974
Sueda S. Clinical usefulness of myocardial scintigraphy in patients with vasospastic angina. J Cardiol 2020;75:494‐9.
pubmed: 31862179
Yasue H, Omote S, Takizawa A, Nagao M. Coronary arterial spasm in ischemic heart disease and its pathogenesis: A review. Circ Res 1983;52:I147‐52.
pubmed: 6339104
Ha JW, Lee JD, Jang Y, Chung N, Kwan J, Rim SJ, et al. 123I-MIBG myocardial scintigraphy as a noninvasive screen for the diagnosis of coronary artery spasm. J Nuclear Cardiol 1998;5:591‐7.
Kline RC, Swanson DP, Wieland DM, Thrall JH, Gross MD, Pitt B, et al. Myocardial imaging in man with I-123 meta-iodobenzylguanidine. J Nucl Med 1981;22:129‐32.
pubmed: 7463156
Inobe Y, Kugiyama K, Miyagi H, Ohgushi M, Tomiguchi S, Takahashi M, et al. Long-lasting abnormalities in cardiac sympathetic nervous system in patients with coronary spastic angina: quantitative analysis with iodine 123 metaiodobenzylguanidine myocardial scintigraphy. Am Heart J 1997;134:112‐8.
pubmed: 9266791
Sisson JC, Wieland DM, Sherman P, Mangner TJ, Tobes MC, Jacques S Jr. Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function. J Nucl Med 1987;28:1620‐4.
pubmed: 3655914
Sakata K, Shirotani M, Yoshida H, Kurata C. Iodine-123 metaiodobenzylguanidine cardiac imaging to identify and localize vasospastic angina without significant coronary artery narrowing. J Am Coll Cardiol 1997;30:370‐6.
pubmed: 9247507
Taki J, Yasuhara S, Takamatsu T, Nakajima K, Tatami R, Ishise S, et al. Value of iodine-123 metaiodobenzylguanidine scintigraphy in patients with vasospastic angina. Eur J Nucl Med 1998;25:229‐34.
pubmed: 9580854
Hirano Y, Ozasa Y, Yamamoto T, Nakagawa K, Uehara H, Yamada S, et al. Diagnosis of vasospastic angina by hyperventilation and cold-pressor stress echocardiography: comparison to I-MIBG myocardial scintigraphy. J Am Soc Echocardiogr 2002;15:617‐23.
pubmed: 12050603
Sakata K, Iida K, Kudo M, Yoshida H, Doi O. Prognostic value of I-123 metaiodobenzylguanidine imaging in vasospastic angina without significant coronary stenosis. Circ J 2005;69:171‐6.
pubmed: 15671608
Nishimiya K, Matsumoto Y, Shindo T, Hanawa K, Hasebe Y, Tsuburaya R, et al. Association of adventitial vasa vasorum and inflammation with coronary hyperconstriction after drug-eluting stent implantation in pigs in vivo. Circ J 2015;79:1787‐98.
pubmed: 26027445
Nishimiya K, Matsumoto Y, Takahashi J, Uzuka H, Odaka Y, Nihei T, et al. In vivo visualization of adventitial vasa vasorum of the human coronary artery on optical frequency domain imaging. Validation study. Circ J 2014;78:2516‐8.
pubmed: 24976390
Nishimiya K, Matsumoto Y, Takahashi J, Uzuka H, Wang H, Tsuburaya R, et al. Enhanced adventitial vasa vasorum formation in patients with vasospastic angina: assessment with OFDI. J Am Coll Cardiol 2016;67:598‐600.
pubmed: 26846957
Martineau P, Grégoire J, Harel F, Pelletier-Galarneau M. Assessing cardiovascular infection and inflammation with FDG-PET. Am J Nucl Med Mol Imaging 2021;11:46‐58.
pubmed: 33688455
pmcid: 7936252
Ohyama K, Matsumoto Y, Takanami K, Ota H, Nishimiya K, Sugisawa J, et al. Coronary adventitial and perivascular adipose tissue inflammation in patients with vasospastic angina. J Am Coll Cardiol 2018;71:414‐25.
pubmed: 29389358